ALFA FinderNSE filing, NSE: IPHL. Summary written from the filing by ALFA Finder's alert engine.
Indian Phosphate Ltd: key numbers
- Share price
- ₹78.20
- Market cap
- ₹195.4 Cr
- Revenue (annual)
- ₹1,072 Cr
- Net profit (annual)
- ₹21.93 Cr
- P/E (TTM)
- 8.9×Sector 11.4×
- Promoter holding
- 72.99%
- FII holding
- 1.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indian Phosphate Ltd
All →Indian Phosphate Other Announcement
Indian Phosphate filed a Reg 27(2) governance non-applicability certificate for Q1 FY2027. The routine compliance filing carries no transaction or financial impact.
Indian Phosphate Business Update
Indian Phosphate's Q2 FY27 update reports strong revenue growth and commercial production at its Cuddalore plant, alongside new fertilizer distribution partnerships and project proposals.
- Anionic Surfactant plant capacity
- 100.0 MT/day
Indian Phosphate Annual General Meeting
Indian Phosphate Limited conducted its 27th Annual General Meeting on September 29, 2026. Key resolutions included adopting financial statements and re-appointing directors and auditors.
Indian Phosphate Annual General Meeting
Indian Phosphate Limited has issued the notice for its 27th Annual General Meeting, scheduled for September 29, 2026, to transact various ordinary and special businesses.
Indian Phosphate Board Meeting Outcome
Indian Phosphate Limited announced the outcome of its board meeting held on September 1, 2026. Key items include approving financial reports and scheduling the 27th AGM.
Indian Phosphate Results Update
Indian Phosphate Limited reported Q1 FY27 consolidated revenue of ₹46.01 Crore. Revenue grew by 81% YoY, driven by strong chemicals and fertilizers performance.
- Value
- ₹46.01 Cr
Other merger & restructuring announcements
All →Zydus Lifesciences Merger & Restructuring
Zydus completed its subscription for 50% of Zydus Sunshine, making it a 50:50 joint venture with Sunshine Healthcare Lanka. Completed November 11, 2026.
Spacenet Enterprises India Merger & Restructuring Worth ₹2.6 Cr
Spacenet sold 40,00,005 String Metaverse shares on 11 November 2026 at ₹6.49 each. Gross consideration of about ₹2.60 Crore is disclosed as material.
- Value
- ₹2.60 Cr
Abans Financial Services Merger & Restructuring Worth ₹1.2 Cr
Abans Financial Services approved incorporating a Hong Kong subsidiary for bullion and securities trading. The cash consideration is Rs 1.20 Crore.
- Value
- ₹1.20 Cr
Adani Enterprises Merger & Restructuring Worth ₹0.94 Cr
Adani Enterprises reported incorporation of Adani Rovuma Chemicals Limited in UAE on November 10, 2026, via Adani Global Limited. Cash consideration of Rs. 0.94 Crore was stated.
- Value
- ₹0.94 Cr
Adani Enterprises Merger & Restructuring
Adani Enterprises' subsidiary Adani Global incorporated Adani Rovuma Chemicals Limited in UAE on November 10, 2026. It is a step-down subsidiary with USD 100,000 paid-up capital.
Kovai Medical Center and Hospital Merger & Restructuring Worth ₹0.85 Cr
Kovai Medical extended the completion deadline for the slump sale of its AHS division to a related-party trust to January 31, 2027. Cash consideration is Rs.84.54 Lakhs.
- Value
- ₹0.85 Cr
- Execution
- Completion expected by 31 January 2027